SHENZHEN, China, April 10 /Xinhua-PRNewswire-FirstCall/ -- Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices in China with a rapidly growing international presence, today announced that it will attend the 2008 China International Medical Equipment Fair.
"We are looking forward to exhibiting some of our over 40 high-quality, competitively priced products at one of Asia's largest and most comprehensive medical device exhibitions," said Mr. Xu Hang, Mindray's chairman and co-chief executive officer. "Mindray's growing suite of innovative products is the result of a disciplined approach to investing in China-based R&D. Our recently FDA-approved, portable M5 ultrasound imaging system is a notable example of our ability to tailor products to meet unique end-user application and pricing needs."
Mindray will display 12 devices from its three core product segments: Patient Monitoring & Life Support Products, In-vitro Diagnostic Products and Medical Imaging Systems.
Mindray currently exports its patient monitoring & life support products, in-vitro diagnostic products and medical imaging systems to more than 140 countries.
About Mindray
Mindray Medical International Limited is a leading developer, manufacturer and marketer of medical devices in China with a significant and growing presence worldwide. Established in 1991, Mindray offers a broad range of products across three primary business segments: patient monitoring & life support products, in-vitro diagnostic products, and medical imaging systems. Mindray is headquartered in Shenzhen, China, and has 29 local sales and service offices in China, as well as sales and service offices in Amsterdam, Istanbul, London, Mexico City, Moscow, Mumbai, Sao Paulo, Seattle, Toronto and Vancouver. For more information, please visit http://www.mindray.com .
Safe Harbor Statement
This press release contains "forward-looking statements" within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Statements that are not historical facts, including statements about new product releases and regulatory approvals are forward- looking statements. Readers are cautioned that these forward-looking statements are only predictions and may differ materially from actual results due to a variety of factors. Forward-looking statements involve inherent risks and uncertainties. Information regarding these risks and uncertainties is included in our public documents filed with the Securities and Exchange Commission. For a discussion of some of the risks and important factors that could affect Mindray's actual results and financial condition, see "Risk Factors" in Part I, Item 3D of Mindray's Annual Report on Form 20-F for the fiscal year ended December 31, 2006 and "Operating and Financial Review and Prospects" in Part I, Item 5 of Mindray's Annual Report on Form 20-F for the fiscal year ended December 31, 2006. Mindray does not undertake any obligation to update any forward-looking statement, except as required under applicable law. All information provided in this press release is as of April 10, 2008, and Mindray undertakes no duty to update such information, except as required under applicable law.
SOURCE Mindray Medical International Limited
